Mass General Brigham Cancer Institute Grand Rounds

Fall 2025 - Spring 2026 Grand Rounds

Time: Thursdays, 12:00 PM–1:00 PM
Course Director: Colin D. Weekes, MD, PhD
Co-Course Directors: E. Chiocca, MD, PhD; Paul Nguyen, MD; Motaz Qadan, MD, PhD

The Mass General Brigham Cancer Institute Grand Rounds program has emerged as a premiere oncology conference in Boston. This program provides an opportunity for Mass General Brigham professional staff and fellows to learn from national and international leaders and innovators in cancer treatment and research. This year’s theme for the series is Science Derived from Mass General Brigham Investigators.

Grand Rounds offers CME credit, and is structured as a 45-minute lecture followed by 15 minutes of discussion and interaction. Please see below to view the weekly topics and presenters.

Outside of Mass General Brigham and interested in viewing the Grand Rounds? Stay tuned to access our new Mass General Brigham Cancer Institute Grand Rounds subscription available to the public.

---

Fall 2025 Grand Rounds Schedule

September 11, 2025
Severe Immunotherapy Complications: Integrating Clinical Insight with Translational Innovation

Kerry Reynolds, MD
Mass General Brigham Cancer Institute

Alexandra-Chloe Villani, MD
Mass General Brigham Cancer Institute

September 18, 2025
The Viral-like Behavior of Cancer

David Ting, MD
Mass General Brigham Cancer Institute

September 25, 2025
A New Era for AML? The Wane of Induction and the Rise of HMA Combinations

Amir Fathi, MD
Mass General Brigham Cancer Institute

October 2, 2025

Moderator: Keith Flaherty, MD
Panelists: Jeff Engelman, MD; Ana Farago, MD; Julian Adams, MD

October 9, 2025
Chabner Lectureship

Dave Tuveson, MD
Cold Spring Harbor

October 16, 2025

Danielle Bitterman, MD
BWH

October 23, 2025
ASCO Review

Speakers TBD

October 30, 2025

Alec Kimmelman, MD, PhD
NYU

November 20, 2025
Defining and overcoming anti-PD-1 resistance

Ryan Sullivan, MD
Mass General Brigham Cancer Institute

December 4, 2025
Rethinking glioblastoma clinical trials: how to avoid sending CAR T cells to the drug graveyard

Stephen Bagley, MD, MSCE
University of Pennsylvania Perelman School of Medicine

December 11, 2025
Thinking Outside the B(oT)ox for the Treatment of AL Amyloidosis and Other Plasma Cell Disorders

Giada Bianchi, MD
Mass General Brigham Cancer Institute

December 18, 2025
Navigating the Changing Treatment Landscape in Locally Advanced Rectal Cancer

Lisa Kachnic, MD
Columbia University